Xavier Santander

Dr. Xavier Santander


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Cytotherapy
Verified
Journal Article
Open access
JVJesús Vaquero
Jesús Vaquero
MZMercedes Zurita
Mercedes Zurita
MRMiguel A. Rico
Miguel A. Rico
CAConcepcion Aguayo
Concepcion Aguayo
CBCelia Bonilla
Celia Bonilla
BRBegoña Rodríguez
Begoña Rodríguez
Cell therapy with autologous mesenchymal stromal cells (MSCs) in patients with spinal cord injury (SCI) is beginning, and the search for its better clinical application is an urgent need. We present a phase 2 clinical trial in patients with chronic SCI who received three intrathecal administrations of 100 x 106 MSCs and were followed for 10 months from the first administration. Efficacy analysis was performed on nine patients, and safety analysis was performed on 11 patients. Clinical scales, urodynamic, neurophysiological and neuroimaging studies were performed previous to treatment and at the end of the follow-up. The treatment was well-tolerated, without any adverse event related to MSC administration. Patients showed variable clinical improvement in sensitivity, motor power, spasms, spasticity, neuropathic pain, sexual function or sphincter dysfunction, regardless of the level or degree of injury, age or time elapsed from the SCI. In the course of follow-up three patients, initially classified as ASIA A, B and C, changed to ASIA B, C and D, respectively. In urodynamic studies, at the end of follow-up, 66.6% of the patients showed decrease in postmicturition residue and improvement in bladder compliance. At this time, neurophysiological studies showed that 55.5% of patients improved in somatosensory or motor-evoked potentials, and that 44.4% of patients improved in voluntary muscle contraction together with infralesional active muscle reinnervation. The present guideline for cell therapy is safe and shows efficacy in patients with SCI, mainly in recovery of sphincter dysfunction, neuropathic pain and sensitivity.


25 June 2019 in Surgical Neurology International
Verified
Journal Article
Open access
XSXavier Santander
Xavier Santander
RGRaquel Gutiérrez-González
Raquel Gutiérrez-González
CCCarlos Cotúa
Carlos Cotúa
EGEva Tejerina Gonzalez
Eva Tejerina Gonzalez
GRGregorio-Boto Rodríguez
Gregorio-Boto Rodríguez
Background: The aim of this study is to highlight the importance of cryptococcosis as one of the most common fungal infections of the central nervous system, stressing the consideration of a cryptococcoma within the list of differential diagnosis of intraventricular masses in immunocompetent hosts.Case Description: We present the case of an immunocompetent 41-year-old female from Philippines with an intraventricular cryptococcoma due toCryptococcus neoformans, mimicking an intraventricular primary brain tumor, who had hydrocephalus. She was approached as having a neoplastic lesion and underwent surgical resection plus third ventriculostomy through endoscopy. Later in her evolution, we realized the infectious nature of the lesion, and antifungal systemic therapy was initiated. In the end, she needed the placement of a ventriculoperitoneal shunt to maintain a good neurologic status. Despite all our efforts, she had a fatal outcome due to various complications.Conclusion: Our case is the first intraventricular cryptococcoma due toC. neoformans, as far as we know, to be reported in English, German, or Spanish literature. Our report stresses the importance to consider this kind of infection in immunocompetent patients, to raise the level of suspicion of this diagnosis, and to know the complications and management options.

9 October 2023 in World Neurosurgery
Verified
Journal Article
Closed access
EPElsa González Pérez
Elsa González Pérez
XSXavier Santander
Xavier Santander
PAPedro Llinás Amengual
Pedro Llinás Amengual
DCDae-Jung Choi
Dae-Jung Choi

30 April 2025 in Asian Spine Journal
Verified
Journal Article
Open access
XSXavier Santander
Xavier Santander
EPElsa González Pérez
Elsa González Pérez
DCDae-Jung Choi
Dae-Jung Choi
Unilateral biportal endoscopy (UBE) has revolutionized minimally invasive spinal surgery, offering enhanced visualization and reduced recovery times. However, the steep learning curve and technical complexity require a structured training framework. This narrative review proposes a 10-tier difficulty progression framework for UBE designed to guide novice surgeons through incremental skill acquisition. Each tier corresponds to specific procedures with escalating challenges spanning lumbar, cervical, and thoracic pathologies. The proposed framework begins with foundational lumbar procedures, such as ipsilateral recess decompression and discectomy, and advances to more intricate techniques, such as transforaminal lumbar interbody fusion. Transitioning to the cervical and thoracic regions requires mastery of earlier tiers, emphasizing precision in handling delicate anatomical structures. These challenges include achieving proficiency in mobilizing nerve roots, minimizing spinal cord manipulation, and mastering advanced decompression techniques. Evidence from learning curve analyses, including cumulative sum methodologies, underscores the importance of tailored training to reduce complications and optimize outcomes. By standardizing the progression of UBE procedures, this framework aims to enhance surgical safety, improve patient outcomes, and facilitate their widespread adoption. Future research should focus on validating this framework by using clinical trials, training feedback, and long-term patient data. Ultimately, this 10-tiered approach provides a roadmap for mastering UBE, addressing the growing demand for minimally invasive spinal surgery with precision and confidence.

16 September 2022 in Surgical Neurology International
Verified
Journal Article
Open access
XSXavier Santander
Xavier Santander
YHYolanda García Hidalgo
Yolanda García Hidalgo
JFJosé Carlos Flores
José Carlos Flores
BGBlanca Gómez-Jordana
Blanca Gómez-Jordana
Background: The sinking skin syndrome (SSS) is a particular complication after a decompressive craniectomy (DC). It still remains a poorly understood and underestimated entity. Methods: Retrospective case series of craniectomized patients with and without SSS. Clinical and radiological features (DC diameter, shape of craniectomy flap, and midline deviation) were described and relative volumes of intracranial loss were quantified. Results: Twenty-seven patients (63% with SSS). The most common indication for DC was traumatic brain injury: 48.15%. The p50 diameter of DC was 12.8 cm for patients with SSS and 11.1 cm for patients without (Z score = 0.32). DC area was 81.5 cm2 for patients with SSS and 71.43 cm2 for patients without the syndrome (Z score = 0.61). According to the shape of the craniectomy flap, we classified our patients as: «same level» (51.8%), «sunken» (25.9%), and «extracranial herniation» (14.8%). Two patients (7.4%) had paradoxical herniation. Midline deviation was present in 12 (70.6%) patients with SSS. The 3rd ventricle volume average was 1.2 cc for patients with SSS versus 2.35 cc for patients without (Z score = 0.04). About 94.11% of patients (16 out of 17) clearly improved after replacement of the cranial defect. Conclusion: In our series, low 3rd ventricle volumes had a good relation with SSS. The presence of a sunken flap does not guarantee SSS per se and we propose the following radiologic description: A = sunken, B = same level, C = extracranial herniation, and D = paradoxical. Replacement of the skull defect is the main treatment.